n. a protein kinase inhibitor used for the treatment of advanced renal cell carcinoma. It targets a serine threonine kinase that regulates a signalling cascade controlling cell proliferation. It is administered by intravenous infusion; side-effects include hypersensitivity reactions (flushing, chest pain, breathlessness). Trade name: Torisel.
Subjects: Clinical Pharmacology and Therapeutics.